Association of CD14 gene −260C>T and −561C>T polymorphisms with cancer susceptibility: A meta‐analysis
Authors:
- 11 December 2019
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 22 (2) , e3151
Abstract
Background: Two polymorphisms, −260C>T (rs2569190) and −561C>T (rs5744455), in the CD14 gene have been implicated in susceptibility to cancer. However, the results remain inconclusive. The current meta‐analysis was carried out aiming to confirm the function of these two polymorphisms on the susceptibility of cancer.Methods: We collected eligible studies from databases, including PubMed, EMBASE, CNKI, Wanfang, and VIP (Weipu). We used logistic regression calculation to compute odds ratios (ORs) and 95% confidence intervals (CIs).Results: After strict selection, 24 studies with 5854 cases and 10339 controls for −260C>T and seven studies with 1809 cases and 7289 controls for −561C>T were finally enlisted into our analysis reference material. Pool results revealed that neither −260C>T, nor −561C>T was found to have any association with overall cancer susceptibility. Nevertheless, when stratified by cancer type, we detected a decreased risk associated with other cancers in a heterozygous model (OR = 0.69, 95% CI = 0.51–0.93, p = 0.014) and a dominant model (OR = 0.70, 95% CI = 0.53–0.93, p = 0.012) for −561C>T. An increased risk was found in other cancers under an allele model (OR = 1.29, 95% CI = 1.03–1.62, p = 0.026), in laryngeal cancer under a dominant model (OR = 1.38, 95% CI = 1.11–1.71, p = 0.003) and for a score ≤ 9 under a recessive model (OR = 1.45, 95% CI = 1.09–1.91, p = 0.009) for −561C>T.Conclusions: In the present study, we conclude that the CD14 –260C>T and −561C>T polymorphisms might not be associated with overall cancer risk. Further studies are encouraged to confirm this conclusion.Keywords
Funding Information
- Natural Science Foundation of Gansu Province (145RJZA105, No. 145RJZA105)
This publication has 41 references indexed in Scilit:
- The Role of TLR2, TLR4 and CD14 Genetic Polymorphisms in Gastric Carcinogenesis: A Case-Control Study and Meta-AnalysisPLOS ONE, 2013
- GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microgliaJournal of Neuroinflammation, 2012
- Association of CD14 variant with prostate cancer in African American menThe Prostate, 2009
- Genetic variants in immunoregulatory genes and risk for childhood lymphomasEuropean Journal of Haematology, 2009
- CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populationsEuropean Journal Of Cancer Prevention, 2009
- Role ofCD14Promoter Polymorphisms inHelicobacter pyloriInfection–Related Gastric CarcinomaClinical Cancer Research, 2007
- The Epigenomics of CancerCell, 2007
- Polymorphism ofCD14gene but not the mutation ofTLR4gene is associated with colorectal cancer in Chinese patientsJournal of Gastroenterology and Hepatology, 2006
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990